SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Naveen R.)
 

Sökning: WFRF:(Naveen R.) > Type 1 diabetes, CO...

Type 1 diabetes, COVID-19 vaccines and short-term safety : Subgroup analysis from the global COVAD study

Chatterjee, Tulika (författare)
Department of Internal Medicine, Center for Outcomes Research, University of Illinois College of Medicine Peoria, Peoria, Illinois, USA
Ravichandran, Naveen (författare)
Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Nair, Narmadha (författare)
Department of Endocrinology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK
visa fler...
Gracia-Ramos, Abraham Edgar (författare)
Department of Internal Medicine, National Medical Center "La Raza", Instituto Mexicano del Seguro Social, General Hospital, Mexico City, Mexico
Barman, Bhupen (författare)
Department of Medicine, All India Institute of Medical Science (AIIMS), Guwahati, India
Sen, Parikshit (författare)
Maulana Azad Medical College, New Delhi, Delhi, India
Joshi, Mrudula (författare)
Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India
Saha, Sreoshy (författare)
Mymensingh Medical College, Mymensingh, Bangladesh
Nune, Arvind (författare)
Department of Rheumatology, Southport and Ormskirk Hospital NHS Trust, Southport, UK
Pande, Arun Kumar R. (författare)
LEDTC Clinic, Lucknow, Uttar Pradesh, India
Velikova, Tsvetelina (författare)
Medical Faculty, Sofia University St. Kliment Ohridski, Sofia, Bulgaria
Parodis, Ioannis, 1981- (författare)
Örebro universitet,Institutionen för medicinska vetenskaper,Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden; Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
Tan, Ai Lyn (författare)
NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals Trust, Leeds, UK; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
Shinjo, Samuel Katsuyuki (författare)
Division of Rheumatology, Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brazil
Boro, Hiya (författare)
Department of Endocrinology and Metabolism, All India Institute of Medical Sciences, New Delhi, India
Agarwal, Vikas (författare)
Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
Aggarwal, Rohit (författare)
Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Gupta, Latika (författare)
Department of Rheumatology, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK; Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine, and Health, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK; Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham, UK
COVAD Study Group, - (bidragsgivare)
visa färre...
 (creator_code:org_t)
John Wiley & Sons, 2024
2024
Engelska.
Ingår i: Journal of Diabetes Investigation. - : John Wiley & Sons. - 2040-1116 .- 2040-1124. ; 15:1, s. 131-138
Relaterad länk:
https://doi.org/10.1...
visa fler...
https://urn.kb.se/re...
https://doi.org/10.1...
http://kipublication...
visa färre...
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • AIMS/INTRODUCTION: Coronavirus disease 2019 (COVID-19) vaccinations have been proven to be generally safe in healthy populations. However, the data on vaccine safety in patients with type 1 diabetes are scarce. This study aimed to evaluate the frequency and severity of short-term (<7-day) adverse vaccination events (AEs) and their risk factors among type 1 diabetes patients. MATERIALS AND METHODS: This study analyzed data from the COVID-19 vaccination in Autoimmune Diseases (COVAD) survey database (May to December 2021; 110 collaborators, 94 countries), comparing <7-day COVID-19 vaccine AE among type 1 diabetes patients and healthy controls (HCs). Descriptive statistics; propensity score matching (1:4) using the variables age, sex and ethnicity; and multivariate analyses were carried out.RESULTS: This study analyzed 5,480 completed survey responses. Of all responses, 5,408 were HCs, 72 were type 1 diabetes patients (43 females, 48.0% white European ancestry) and Pfizer was the most administered vaccine (39%). A total of 4,052 (73.9%) respondents had received two vaccine doses. Patients with type 1 diabetes had a comparable risk of injection site pain, minor and major vaccine AEs, as well as associated hospitalizations to HCs. However, type 1 diabetes patients had a higher risk of severe rashes (3% vs 0.4%, OR 8.0, 95% confidence interval 1.7-36), P = 0.007), although reassuringly, these were rare (n = 2 among type 1 diabetes patients).CONCLUSIONS: COVID-19 vaccination was safe and well tolerated in patients with type 1 diabetes with similar AE profiles compared with HCs, although severe rashes were more common in type 1 diabetes patients.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)

Nyckelord

COVID-19
Type 1 diabetes mellitus
Vaccine

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy